Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-26 @ 10:36 AM
NCT ID:
NCT01333228
Eligibility Criteria:
Inclusion Criteria:
* Liver cirrhosis (Child-Pugh 8 or above).
* Ability to sign informed consent
Exclusion Criteria:
* Age \<18 or \>75
* Variceal bleeding or severe infection within the past 30 days before screening
* Chronic encephalopathy preventing the ability to sign informed consent (it could be done by legal representant of the patient) and/or the ability to follow the study protocol
* Hepatocellular carcinoma (previous or current)
* Any current or previous malignancy (within 5 years before the inclusion) except "in situ" tumors or skin basal cell carcinomas
* Any severe extrahepatic disease during the past 30 days before the inclusion
* Any current decompensated chronic disease
* Any contraindication for the examinations of the clinical protocol (medullar aspiration, arteriography, HVPG measurement)
* Any other condition that could negatively affect the compliance with the protocol
* Pregnant or breast-feeding women
* Participation in a trial of an experimental drug or device within 30 days before screening
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01333228
Study Brief:
Protocol Section:
NCT01333228